GlassScriptPhysician profile
Melanie Metsa
NPI 1447255807
$2,080.62
in general payments reported to CMS, 2019-2025
19 companies · $613 in 2025
The $613 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.63 · 2020: $119 · 2021: $300 · 2022: $236 · 2023: $259 · 2024: $472 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $444.65 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb Americas INC. | $236.44 | 2022-2024 | Infuse, Vyzulta, Xiidra |
| Alcon Vision LLC | $209.57 | 2022-2025 | Rocklatan, Eysuvis |
| Aerie Pharmaceuticals, INC. | $209.50 | 2019-2021 | |
| Glaukos Corporation | $208.52 | 2025 | Istent, Idosetr |
| Tarsus Pharmaceuticals, INC. | $157.41 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $124.99 | 2023 | Tepezza |
| Abbvie INC. | $95.19 | 2025 | |
| Oyster Point Pharma, INC. | $75.86 | 2022-2024 | Tyrvaya |
| Amgen INC. | $75.39 | 2024 | Tepezza |
| Shire North American Group INC | $43.21 | 2019 | |
| Kala Pharmaceuticals, INC. | $41.62 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $33.15 | 2022 | |
| Rxsight INC | $24.67 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Thea Pharma INC. | $24.02 | 2025 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.13 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.34 | 2020 | |
| Allergan, INC. | $16.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Metsa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.